Login

Capital- Building Engaged Crypto Communities|Niv Dror,Managing Partner,Shrug Capital 00:10:00

Share On Facebook Share On Twitter

Niv Dror is a Managing Partner at Shrug Capital.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The American Challenge: Peter Thiel on Economic Expectations and Reality|Peter Thiel
00:10:00
Shilpa Kumar, MD & CEO of ICICI Securities, discusses the impact of the TER decrease on the mutual funds industry.
00:10:00
Introducing Landis & Morningstar: Secure, Insightful Portfolio Management
00:00:00
Imugene sees positive early signals in Phase 1 VAXINIA study - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:00:00
Richard Marsden Chief Executive Officer, Executive Director, Synairgen
00:10:00
Insights on Gold Focus and Investor Engagement at a One-to-One Conference
00:10:00
Michael Vodicka analyzes Diodes, Inc. (DIOD) for its semiconductor prospects and Central Garden & Pet Company for its position in the consumer goods market.|Keh-Shew Lu. Chairman and Chief Executive Officer of Diodes, Inc
00:10:00
Commerzbank's Strategy Amid Germany's Economic Challenges | Manfred Knof , CEO ,  Commerzbank.
00:10:00
The entrepreneur and the company-building process|Marc Andreessen,Investor, Andreessen Horowitz
00:10:00
First Cobalt Explorer Targets North American Supply Amid Growing EV Demand
00:10:00
Navigating Change: Amica SA's 25-Year Journey on the WSE | Jacek Rutkowski, President , Amica SA.
00:10:00
ambitious teams to positively transform life as we know it|Alex Ferrara,Partner,Bessemer Venture Partners

© 2017 - Neuhu+